PT88217A - Processo para a preparacao de uma composicao antibiotica soluvel em agua e de sais soluveis em agua de novos compostos cefem - Google Patents

Processo para a preparacao de uma composicao antibiotica soluvel em agua e de sais soluveis em agua de novos compostos cefem

Info

Publication number
PT88217A
PT88217A PT88217A PT8821788A PT88217A PT 88217 A PT88217 A PT 88217A PT 88217 A PT88217 A PT 88217A PT 8821788 A PT8821788 A PT 8821788A PT 88217 A PT88217 A PT 88217A
Authority
PT
Portugal
Prior art keywords
water
cefem
soluable
preparation
soluble salts
Prior art date
Application number
PT88217A
Other languages
English (en)
Other versions
PT88217B (pt
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878718905A external-priority patent/GB8718905D0/en
Priority claimed from GB878721567A external-priority patent/GB8721567D0/en
Priority claimed from GB878725051A external-priority patent/GB8725051D0/en
Priority claimed from GB878729574A external-priority patent/GB8729574D0/en
Priority claimed from GB888801423A external-priority patent/GB8801423D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT88217A publication Critical patent/PT88217A/pt
Publication of PT88217B publication Critical patent/PT88217B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT88217A 1987-08-10 1988-08-08 Processo para a preparacao de uma composicao antibiotica soluvel em agua e de sais soluveis em agua de novos compostos cefem PT88217B (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB878718905A GB8718905D0 (en) 1987-08-10 1987-08-10 Salts of new cephem compounds
GB878721567A GB8721567D0 (en) 1987-09-14 1987-09-14 Salts of cephem compounds
GB878725051A GB8725051D0 (en) 1987-10-26 1987-10-26 Salts of cephem compounds
GB878729574A GB8729574D0 (en) 1987-12-18 1987-12-18 Water-soluble antibiotic composition
GB888801423A GB8801423D0 (en) 1988-01-22 1988-01-22 Water-soluble antibiotic composition

Publications (2)

Publication Number Publication Date
PT88217A true PT88217A (pt) 1989-06-30
PT88217B PT88217B (pt) 1995-03-01

Family

ID=27516755

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88217A PT88217B (pt) 1987-08-10 1988-08-08 Processo para a preparacao de uma composicao antibiotica soluvel em agua e de sais soluveis em agua de novos compostos cefem

Country Status (16)

Country Link
US (1) US5104866A (pt)
EP (1) EP0303223B1 (pt)
JP (1) JP2625937B2 (pt)
KR (1) KR970008127B1 (pt)
AR (1) AR243380A1 (pt)
AU (1) AU616677B2 (pt)
CA (1) CA1338780C (pt)
DE (1) DE3885031T2 (pt)
DK (1) DK445188A (pt)
ES (1) ES2059454T3 (pt)
FI (1) FI89927C (pt)
HU (2) HU210848B (pt)
IE (1) IE61679B1 (pt)
IL (1) IL87364A0 (pt)
NO (1) NO175963C (pt)
PT (1) PT88217B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100572323B1 (ko) 2003-12-11 2006-04-19 삼성전자주식회사 멀티레벨 고전압 발생장치
JP5498393B2 (ja) * 2008-10-31 2014-05-21 塩野義製薬株式会社 カテコール基を有するセファロスポリン類
US8883773B2 (en) * 2010-04-05 2014-11-11 Shionogi & Co., Ltd. Cephem compound having pseudo-catechol group
IN2012CN09242A (pt) 2010-04-05 2015-08-21 Shionogi & Co
US20130065874A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4338313A (en) * 1979-10-12 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4332800A (en) * 1979-10-12 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR890003782A (ko) 1989-04-18
DK445188D0 (da) 1988-08-09
JPH01110690A (ja) 1989-04-27
NO883530D0 (no) 1988-08-09
DK445188A (da) 1989-02-11
DE3885031D1 (de) 1993-11-25
HU211940A9 (en) 1996-01-29
NO175963C (no) 1995-01-11
ES2059454T3 (es) 1994-11-16
DE3885031T2 (de) 1994-02-17
AU616677B2 (en) 1991-11-07
AR243380A1 (es) 1993-08-31
KR970008127B1 (ko) 1997-05-21
JP2625937B2 (ja) 1997-07-02
AU2059888A (en) 1989-02-16
FI883696A0 (fi) 1988-08-09
CA1338780C (en) 1996-12-10
IL87364A0 (en) 1989-01-31
US5104866A (en) 1992-04-14
FI883696A (fi) 1989-02-11
EP0303223A2 (en) 1989-02-15
HUT47943A (en) 1989-04-28
NO883530L (no) 1989-02-13
HU210848B (en) 1995-08-28
FI89927C (fi) 1993-12-10
EP0303223A3 (en) 1990-11-28
IE882365L (en) 1989-02-10
FI89927B (fi) 1993-08-31
IE61679B1 (en) 1994-11-16
PT88217B (pt) 1995-03-01
EP0303223B1 (en) 1993-10-20
NO175963B (no) 1994-10-03

Similar Documents

Publication Publication Date Title
BR1100658A (pt) Composto heterocìclico, composição farmacêutica na forma de dosagem unitária, e, processo para a preparação de um composto heterocìclico
PT81889B (pt) Processo para a preparacao de derivados de aril-1,4-dihidro-4-oxonaftiridina substituidos na posicao 1 e de compostos intermedios utilizaveis nesse processo
BR8904317A (pt) Composicao de ester oligomerico sulfonado e processo para a preparacao da mesma;forma de sal sodico de um ester oligomerico sulfonado;e composicao detergente
PT81583B (pt) Processo para a preparacao de composicoes farmaceuticas analgesicas contendo buprenorfina e naltrexona
PT92481A (pt) Processo para a preparacao de composicoes de revestimento coloridas em po
PT88194A (pt) Processo para a preparacao de microemulsoes microbicidas de isotiazolonas com pequena solubilidade em agua
PT91299A (pt) Processo para a preparacao de aminometiltetralinas substituidas e de seus analogos heterociclicos
PT80361B (pt) Processo para a preparacao de agentes antiulcera de 2-(n-guanidino-substituido)-4-heterdariltiazol e dos seus sais farmaceuticamente aceitaveis
BR8605394A (pt) Composicao detergente granular e processo para a sua preparacao
PT92919A (pt) Processo para a preparacao de agentes ansioliticos bis-azabiciclicos
PT84530B (pt) Processo para a preparacao de 2-azolilmetil-2-aril-1,3-dioxolanos, dos seus sais e de composicoes farmaceuticas que os contem
PT88217A (pt) Processo para a preparacao de uma composicao antibiotica soluvel em agua e de sais soluveis em agua de novos compostos cefem
PT82769B (pt) Processo para a preparacao de derivados de acidos tiazolidino-4(s)-caboxilicos
BR8902915A (pt) Composicao microbicida e processo para a preparacao de compostos
PT81760B (pt) Processo para a preparacao de compostos de podofilotoxina e seus derivados e de composicoes farmaceuticas contendo os mesmos
LU90240I2 (fr) Tilmicosine et les sels d'addition d'acide de celle-ci (micotil r)
PT81911B (pt) Processo para a preparacao de uma composicao amaciadora de tecidos contendo sais de amonio ou de alquilimidazolinio
PT81714B (pt) Processo para a preparacao de composicoes farmaceuticas de teofilina com efeito retardado
PT81531B (pt) Processo para a preparacao de silibinina isenta de isosilibina e de composicoes farmaceuticas contendo silibinina
PT82435B (pt) Processo para a preparacao de compostos intermedios utilizados na sintese de antibioticos carbapenemicos
BR8702278A (pt) Processo para a preparacao de um composto e composicao
BR8900866A (pt) Composicao oleaginosa e processo para a formacao de um concentrado de melhorada estabilidade em armazenagem
PT89956A (pt) Processo para a preparacao de acidos 1-ciclopropil-quinolonocarboxilicos e seus derivados
FR2578422B1 (fr) Composition de traitement a usage topique externe a base de luteoline et procede de preparation
PT89748A (pt) Processo para a preparacao de novos compostos intermedios utilizados na preparacao de compostos tetrazolicos com accao anti-hipercolesterolemica

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940822

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020228